NASDAQ
Climb Bio, Inc. (CLYM) has a free cash flow growth of 8.03% as of Friday, May 29, 2026. This represents a 117.00% increase compared to its 12-month average of -47.26%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.